BC
FSTX

Brookfield Corp’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Brookfield Corp’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-50,000
Closed -$316K – 812
2022
Q4 		$316K Buy
+50,000
New +$316K ﹤0.01% 539